Warfarin vs. Savaysa

See how Warfarin and Savaysa compare on approved uses, dosing, side effects, and cost.

Key Takeaways

  • Warfarin is an older vitamin K antagonist that needs regular blood testing, while Savaysa is a newer factor Xa inhibitor taken at a fixed daily dose without routine monitoring.

  • Savaysa is not recommended for atrial fibrillation patients with very good kidney function, a situation where warfarin remains effective.

  • Warfarin costs far less out of pocket than Savaysa, but Savaysa avoids the dietary restrictions and frequent INR checks warfarin requires.

Warfarin vs. Savaysa Drug Summary

Warfarin

Warfarin is a vitamin K antagonist that has been used since 1954 to prevent and treat blood clots, including those linked to atrial fibrillation, heart valve replacement, and pulmonary embolism. It is taken as a daily tablet, but the dose must be adjusted over time based on regular INR blood tests.

Savaysa

Savaysa (edoxaban) is a factor Xa inhibitor approved in 2015 to prevent stroke in atrial fibrillation and to treat deep vein thrombosis and pulmonary embolism. It is taken as a single fixed-dose tablet each day and does not require routine blood test monitoring.

Warfarin vs. Savaysa Side Effects

Warfarin

Most common
Hemorrhage (rate not quantified)
Necrosis/gangrene (rate not reported)
Calciphylaxis (rate not reported)
Purple toes syndrome (rate not reported)

Savaysa

Most common
Bleeding (any) (up to 21.7%)
Anemia (9.6%)
Abnormal liver function tests (4.8%)
Rash (4.2%)

Warfarin vs. Savaysa Dosage

Warfarin

Dosage
Dosage Table
STAGE DOSE WHEN
Starting dose 2 mg to 5 mg once daily Days 1-4
Maximum dose 2 mg to 10 mg once daily Day 5 onward
Dose changes 1 increase Every 4 days

Savaysa

Dosage
Dosage Table
STAGE DOSE WHEN
Starting dose 60 mg once daily At the start
Maximum dose 30 mg once daily If needed
Dose changes 1 increase As tolerated

Warfarin vs. Savaysa Indications

Warfarin

Warfarin treats and prevents a wide range of clotting problems, including venous thromboembolism, pulmonary embolism, and clots related to atrial fibrillation or mechanical heart valves. It is also used after a heart attack to lower the risk of death, another heart attack, or stroke.

  • Venous thromboembolism prevention and treatment

  • Pulmonary embolism prevention and treatment

  • Stroke prevention in atrial fibrillation

Savaysa

Savaysa is approved to lower the risk of stroke in people with nonvalvular atrial fibrillation and to treat deep vein thrombosis and pulmonary embolism. It is not approved for people with mechanical heart valves or for atrial fibrillation patients whose kidneys clear the drug too quickly.

  • Stroke prevention in nonvalvular atrial fibrillation

  • Deep vein thrombosis (DVT) treatment

  • Pulmonary embolism (PE) treatment

Warfarin vs. Savaysa Pros and Cons

Warfarin

Warfarin has decades of data across more clinical situations than Savaysa, including mechanical heart valves and certain pregnancies, and it costs far less. The tradeoff is regular blood testing and sensitivity to diet and other medications.

Pros

  • Effective across more approved conditions, including heart valves

  • Only oral anticoagulant option for pregnant patients with mechanical valves

  • Effect can be reversed quickly with vitamin K if needed

  • Roughly $4 to $35 per month, far less than Savaysa

Cons

  • Requires regular INR blood testing to find the right dose

  • Affected by vitamin K in food and many drug interactions

  • Takes several days to reach a stable therapeutic effect

  • Risk of skin necrosis or calciphylaxis in rare cases

Savaysa

Savaysa offers simpler, fixed daily dosing without routine blood test monitoring, but it is not an option for mechanical heart valves and works less well with excellent kidney function. It also costs substantially more than warfarin out of pocket.

Pros

  • No routine blood test monitoring required

  • Simple fixed daily dose, not adjusted by lab results

  • Faster onset of anticoagulant effect than warfarin

  • Fewer known food and drug interactions than warfarin

Cons

  • Not recommended for atrial fibrillation with very good kidney function

  • Cannot be used with mechanical heart valves

  • Needs several days of injectable anticoagulant first for DVT/PE

  • Roughly $483 to $561 per month, much more than warfarin

Common Symptoms and Related Diseases You Can Explore

Explore a range of common symptoms the Doctronic Symptom Checker can help you understand.